patent/IE-781619-L

Predicate	Object
assignee	http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_76195fd1cd08192222699d8e7a88c231
classificationCPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-572
classificationIPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/H01L29-78 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-572 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-675 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/H01L29-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-42
filingDate	1978-08-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate	1979-02-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber	IE-781619-L
titleOfInvention	Phosphonoacyl proline compounds.
abstract	New phosphonoacyl prolines and related compounds have the general formula <CHEM> where R1 and R2 each is hydrogen, lower alkyl, lower alkenyl, unsubstituted or substituted phenyl-lower alkyl, or a metal ion;R3 is hydrogen or lower alkyl;R4 is hydrogen, lower alkyl, phenyl-lower alkyl or a metal ion; and n is 0 or 1. <??>These compounds may be used as hypotensive agents in the treatment of mammals. n[EP0000833A1]
priorityDate	1977-08-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type	http://data.epo.org/linked-data/def/patent/Publication

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397385

Total number of triples: 18.